サンプル依頼リスト カート
  • English
  • Korean
市場調査レポート
商品コード
1552457

OTC医薬品および栄養補助食品の世界市場：2033年までの機会と戦略

OTC Drug And Dietary Supplement Global Market Opportunities And Strategies To 2033
出版日: | 発行: The Business Research Company | ページ情報: 英文 324 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=150.96円
OTC医薬品および栄養補助食品の世界市場：2033年までの機会と戦略
出版日: 2024年09月05日
発行: The Business Research Company
ページ情報: 英文 324 Pages
納期: 2～3営業日
  • 全表示
  • 概要
  • 目次
概要

世界のOTC医薬品および栄養補助食品市場は2018年に2,233億1,290万米ドルと評価され、2023年までCAGR6.0％以上で成長しました。

医薬品研究開発（R&D）支出の増加

製薬会社の研究開発（R&D）支出の増加がこれまでのOTC医薬品および栄養補助食品市場の成長を牽引しました。研究開発（R&D）への投資の増加は、先進的なOTC医薬品および栄養補助食品の創出につながった。これらの技術革新は、優れた製剤、改良された送達方法、安全基準の改善を包含し、消費者の間で製品の魅力を高めています。例えば、ベルギーを拠点とする製薬業界団体である欧州製薬団体連合会（European Federation of Pharmaceuticals Industries and Associations）が発表した報告書によると、2021年には欧州の製薬業界が研究開発費として約415億ユーロ（444億7,000万米ドル）を投じ、2020年の396億5,000万ユーロ（424億9,000万米ドル）に比べて増加するといいます。したがって、製薬会社の研究開発（R&D）支出の増加がOTC医薬品および栄養補助食品市場の成長を支えています。

目次

第1章 エグゼクティブサマリー

  • OTC医薬品および栄養補助食品-市場の魅力とマクロ経済情勢

第2章 目次

第3章 表一覧

第4章 図一覧

第5章 レポート構成

第6章 市場の特徴

  • 一般的な市場の定義
  • 概要
  • OTC医薬品および栄養補助食品-市場定義とセグメンテーション
  • 市場セグメンテーション：カテゴリ別
    • ビタミンと栄養補助食品
    • 咳止め・風邪薬
    • 鎮痛剤
    • 胃腸薬
    • 皮膚
    • その他のカテゴリー
  • 市場セグメンテーション：剤形別
    • 錠剤
    • ハードカプセル
    • 粉末
    • 軟膏
    • ソフトカプセル
    • 液体
    • その他の剤形
  • 市場セグメンテーション：流通チャネル別
    • 薬局
    • 食料品店
    • ビタミンと健康食品店
    • オンライン薬局

第7章 主要な市場動向

  • 栄養補助食品およびOTC医薬品の生産能力の拡大
  • オピオイド過剰摂取を逆転させる新しい市販薬の選択肢
  • 授乳中の母親のための天然ハーブベースのサプリメントの発売
  • 痛みやアレルギーを和らげる市販薬ラインのイントロダクション
  • 女性の健康医薬品のイノベーション

第8章 OTC医薬品および栄養補助食品市場- マクロ経済シナリオ

  • COVID-19の影響： OTC医薬品および栄養補助食品市場
  • ウクライナ戦争の影響： OTC医薬品および栄養補助食品市場
  • 高インフレの影響： OTC医薬品および栄養補助食品市場

第9章 世界の市場規模と成長

  • 市場規模
  • 市場成長実績, 2018-2023
    • 市場促進要因, 2018-2023
    • 市場抑制要因, 2018-2023
  • 市場成長予測, 2023-2028, 2033F
    • 市場促進要因, 2023-2028
    • 市場抑制要因, 2023-2028

第10章 世界のOTC医薬品および栄養補助食品市場：セグメンテーション

  • 世界のOTC医薬品および栄養補助食品市場：カテゴリ別、実績と予測, 2018-2023, 2028F, 2033F
  • 世界のOTC医薬品および栄養補助食品市場：剤形別、実績と予測, 2018-2023, 2028F, 2033F
  • 世界のOTC医薬品および栄養補助食品市場：流通チャネル別、実績と予測, 2018-2023, 2028F, 2033F

第11章 OTC医薬品および栄養補助食品市場：地域・国別分析

  • 世界のOTC医薬品および栄養補助食品市場：地域別、実績と予測, 2018-2023, 2028F, 2033F
  • 世界のOTC医薬品および栄養補助食品市場：国別、実績と予測, 2018-2023, 2028F, 2033F

第12章 アジア太平洋市場

第13章 西欧市場

第14章 東欧市場

第15章 北米市場

第16章 南米市場

第17章 中東市場

第18章 アフリカ市場

第19章 競合情勢と企業プロファイル

  • 企業プロファイル
  • Nestle S.A.
  • The Procter & Gamble Company
  • Haleon plc
  • Abbott Laboratories
  • Sanofi S.A

第20章 その他の大手企業と革新的企業

  • Reckitt Benckiser Group plc
  • Bayer AG
  • Church & Dwight Co. Inc
  • Nature's Bounty Co
  • Perrigo Company plc
  • GNC Holdings Inc.
  • Sun Pharmaceutical Industries Ltd
  • Novartis AG
  • Pfizer Inc
  • Merck & Co. Inc
  • Pharmavite LLC
  • Hain Celestial Group Inc
  • Blackmores Limited
  • Cipla Inc
  • Amway

第21章 競合ベンチマーキング

第22章 競合ダッシュボード

第23章 主要な合併と買収

  • Dr. Reddy's Laboratories Acquired MenoLabs
  • Dexcel Pharma Acquired Teva Pharmaceutical Industries Ltd
  • Cipla Limited Acquired Actor Pharma
  • SGS S.A. Acquired Nutrasource Pharmaceutical and Nutraceutical Services Inc.
  • The Kirin Holdings Company Limited Acquired Blackmores Limited
  • Balchem Corporation Acquired Bergstrom Nutrition
  • Glenmark Pharmaceuticals Ltd Acquired Wockhardt Ltd
  • Acino Acquired Aspen Pharmacare Holdings Limited
  • Douglas Acquired Disapo
  • Merieux NutriSciences Acquired Dyad Labs
  • Laboratorios Rubio Acquired Fisiopharma S.r.l.
  • Fidia Farmaceutici Acquired Sanofi

第24章 機会と戦略

  • 世界のOTC医薬品および栄養補助食品市場、2028：新たな機会を提供する国
  • 世界のOTC医薬品および栄養補助食品市場、2028：新たな機会を提供するセグメント
  • 世界のOTC医薬品および栄養補助食品市場、2028：成長戦略
    • 市場動向に基づく戦略
    • 競合の戦略

第25章 OTC医薬品および栄養補助食品市場：結論と提言

  • 結論
  • 提言
    • 製品
    • 場所
    • 価格
    • プロモーション
    • 人々

第26章 付録

目次
Product Code: o&s1314

The OTC (over the counter) drug and dietary supplement market encompasses products that consumers can purchase without a prescription for self-care and health maintenance.

The OTC drugs and dietary supplement market consists of sales, by entities (organizations, sole traders and partnerships), of OTC drugs and dietary supplement. OTC drugs are used to treat various minor health issues, while dietary supplements provide nutritional support, such as vitamins, minerals, and other substances. These products are widely utilized by individuals seeking to manage minor ailments or boost their overall health without the need for medical consultation. They play a critical role in public health by offering accessible and often more affordable options for symptom relief and wellness.

The global OTC drug and dietary supplement market was valued at $223,312.9 million in 2018 which grew till 2023 at a compound annual growth rate (CAGR) of more than 6.0%.

Rise In Pharma Research And Development (R&D) Expenditure

During the historic period, the rise in pharma research and development (R&D) expenditure drove the growth of the OTC drug and dietary supplement market. Increased investment in research and development (R&D) resulted in the creation of advanced OTC drugs and dietary supplements. These innovations encompassed superior formulations, enhanced delivery methods and improved safety standards, enhancing product appeal among consumers. For instance, according to a report published by the European Federation of Pharmaceutical Industries and Associations, a Belgium-based pharmaceuticals-based trade association, in 2021 European health industries invested about 41.5 billion euros ($44.47 billion) for research and development (R&D) expenditure, an increase compared to 39.65 billion euros ($42.49 billion) in 2020. Therefore, a rise in pharma research and development (R&D) expenditure supported the growth of the OTC drug and dietary supplement market.

New Over-The-Counter Option For Opioid Overdose Reversal

Companies operating in the OTC drug and dietary supplement market are deploying new over-the-counter options for opioid overdose reversal. It facilitates access to a critical life-saving intervention, potentially lowering fatalities in emergency scenarios where immediate medical help may be limited or unavailable. For instance, in April 2024, Amneal Pharmaceuticals, Inc., a US-based generics and specialty pharmaceutical company, has announced the U.S. FDA approval and availability of its over-the-counter (OTC) Naloxone Hydrochloride (Naloxone HCI) Nasal Spray, USP, 4mg. This product is a generic equivalent to OTC NARCAN(R) HCI Nasal Spray and is intended for the emergency treatment of opioid overdoses, including those involving heroin, fentanyl and prescription opioids. Amneal's Naloxone HCI Nasal Spray is formulated to quickly reverse the life-threatening effects of an opioid overdose by binding to opioid receptors and restoring normal respiration within two to three minutes in individuals whose breathing has significantly slowed or stopped.

The global OTC drug and dietary supplement market is fragmented, with a few large number of players operating in the market. The top ten competitors in the market made up 21.5% of the total market in 2023.

OTC Drug And Dietary Supplement Global Market Opportunities And Strategies To 2033 from The Business Research Company provides the strategists; marketers and senior management with the critical information they need to assess the global OTC drug and dietary supplement market as it emerges from the COVID-19 shut down.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis.

Where is the largest and fastest-growing market for OTC drug and dietary supplement? How does the market relate to the overall economy; demography and other similar markets? What forces will shape the market going forward? The OTC drug and dietary supplement market global report from The Business Research Company answers all these questions and many more.

The report covers market characteristics; size and growth; segmentation; regional and country breakdowns; competitive landscape; market shares; trends and strategies for this market. It traces the market's history and forecasts market growth by geography. It places the market within the context of the wider OTC drug and dietary supplement market; and compares it with other markets.

The report covers the following chapters

  • Introduction and Market Characteristics- Brief introduction to the segmentations covered in the market, definitions and explanations about the segment by category, by dosage form and by distribution channel.
  • Key Trends- Highlights the major trends shaping the global market. This section also highlights likely future developments in the market.
  • Macro-Economic Scenario- The report provides an analysis of the impact of the COVID-19 pandemic, impact of the Russia-Ukraine war and impact of rising inflation on global and regional markets, providing strategic insights for businesses in the OTC drug and dietary supplement market.
  • Global Market Size And Growth- Global historic (2018-2023) and forecast (2023-2028, 2033F) market values and drivers and restraints that support and control the growth of the market in the historic and forecast periods.
  • Regional And Country Analysis- Historic (2018-2023) and forecast (2023-2028, 2033F) market values and growth and market share comparison by region and country.
  • Market Segmentation- Contains the market values (2018-2023) (2023-2028, 2033F) and analysis for each segment by category, by dosage form and by distribution channel in the market. Historic (2018-2023) and forecast (2023-2028) and (2028-2033) market values and growth and market share comparison by region market.
  • Regional Market Size and Growth- Regional market size (2023), historic (2018-2023) and forecast (2023-2028, 2033F) market values and growth and market share comparison of countries within the region. This report includes information on all the regions Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa and major countries within each region.
  • Competitive Landscape- Details on the competitive landscape of the market, estimated market shares and company profiles of the leading players.
  • Other Major And Innovative Companies- Details on the company profiles of other major and innovative companies in the market.
  • Competitive Benchmarking- Briefs on the financials comparison between major players in the market.
  • Competitive Dashboard- Briefs on competitive dashboard of major players.
  • Key Mergers and Acquisitions- Information on recent mergers and acquisitions in the market is covered in the report. This section gives key financial details of mergers and acquisitions which have shaped the market in recent years.
  • Market Opportunities And Strategies- Describes market opportunities and strategies based on findings of the research, with information on growth opportunities across countries, segments and strategies to be followed in those markets.
  • Conclusions And Recommendations- This section includes recommendations for OTC drugs and dietary supplement providers in terms of product/service offerings geographic expansion, marketing strategies and target groups.
  • Appendix- This section includes details on the NAICS codes covered, abbreviations and currencies codes used in this report.

Markets Covered:

  • 1) By Category: Vitamin And Dietary Supplements; Cough And Cold Dosage Forms; Analgesics; Gastrointestinal Dosage Forms; Skin; Other Categories
  • 2) By Dosage Form: Tablets; Hard Capsules; Powders; Ointments; Soft Capsules; Liquids; Other Dosage Forms
  • 3) By Distribution Channel: Pharmacies; Grocery Stores; Vitamin And Health Food Stores; Online Pharmacies
  • Companies Mentioned: Nestle S.A.; Procter & Gamble Co.; Haleon plc; Abbott Laboratories; Sanofi S.A.
  • Countries: China; Australia; India; Indonesia; Japan; South Korea; USA; Canada; Brazil; France; Germany; Italy; Spain; UK; Russia
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time-series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets; GDP proportions; expenditure per capita; OTC drug and dietary supplement indicators comparison.
  • Data segmentations: Country and regional historic and forecast data; market share of competitors; market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Table of Contents

1 Executive Summary

  • 1.1 OTC Drug And Dietary Supplement - Market Attractiveness And Macro economic Landscape

2 Table Of Contents

3 List Of Tables

4 List Of Figures

5 Report Structure

6 Market Characteristics

  • 6.1 General Market Definition
  • 6.2 Summary
  • 6.3 OTC Drug And Dietary Supplement Market Definition And Segmentations
  • 6.4 Market Segmentation By Category
    • 6.4.1 Vitamin And Dietary Supplements
    • 6.4.2 Cough And Cold Products
    • 6.4.3 Analgesics
    • 6.4.4 Gastrointestinal Products
    • 6.4.5 Skin
    • 6.4.6 Other Categories
  • 6.5 Market Segmentation By Dosage Form
    • 6.5.1 Tablets
    • 6.5.2 Hard Capsules
    • 6.5.3 Powders
    • 6.5.4 Ointments
    • 6.5.5 Soft Capsules
    • 6.5.6 Liquids
    • 6.5.7 Other Dosage Forms
  • 6.6 Market Segmentation By Distribution Channel
    • 6.6.1 Pharmacies
    • 6.6.2 Grocery Stores
    • 6.6.3 Vitamin And Health Food Stores
    • 6.6.4 Online Pharmacies

7 Major Market Trends

  • 7.1 Expansion Of Production Capabilities In Dietary Supplements And OTC Drugs
  • 7.2 New Over-The-Counter Option For Opioid Overdose Reversal
  • 7.3 Launch Of Natural Herb-Based Supplement For Nursing Mothers
  • 7.4 Introduction Of OTC Drug Line For Pain And Allergy Relief
  • 7.5 Innovation In Women's Health Pharmaceuticals

8 OTC Drug And Dietary Supplement Market - Macro-Economic Scenario

  • 8.1 COVID-19 Impact On The OTC Drug And Dietary Supplement Market
  • 8.2 Impact Of The War In Ukraine On The OTC Drug And Dietary Supplement Market
  • 8.3 Impact Of High Inflation On The OTC Drug And Dietary Supplement Market

9 Global Market Size And Growth

  • 9.1 Market Size
  • 9.2 Historic Market Growth, 2018 - 2023, Value ($ Million)
    • 9.2.1 Market Drivers 2018 - 2023
    • 9.2.2 Market Restraints 2018 - 2023
  • 9.3 Forecast Market Growth, 2023 - 2028, 2033F Value ($ Million)
    • 9.3.1 Market Drivers 2023 - 2028
    • 9.3.2 Market Restraints 2023 - 2028

10 Global OTC Drug And Dietary Supplement Market Segmentation

  • 10.1 Global OTC Drug And Dietary Supplement Market, Segmentation By Category, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 10.2 Global OTC Drug And Dietary Supplement Market, Segmentation By Dosage Form, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 10.3 Global OTC Drug And Dietary Supplement Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

11 OTC Drug And Dietary Supplement Market, Regional and Country Analysis

  • 11.1 Global OTC Drug And Dietary Supplement Market, By Region, Historic and Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 11.2 Global OTC Drug And Dietary Supplement Market, By Country, Historic and Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

12 Asia-Pacific Market

  • 12.1 Summary
    • 12.1.1 Market Overview
    • 12.1.2 Region Information
    • 12.1.3 Market Information
    • 12.1.4 Background Information
    • 12.1.5 Government Initiatives
    • 12.1.6 Regulations
    • 12.1.7 Regulatory Bodies
    • 12.1.8 Major Associations
    • 12.1.9 Taxes Levied
    • 12.1.10 Corporate Tax Structure
    • 12.1.11 Investments
    • 12.1.12 Major Companies
  • 12.2 Asia-Pacific OTC drug And Dietary Supplement Market, Segmentation By Category, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.3 Asia-Pacific OTC drug And Dietary Supplement Market, Segmentation By Dosage Form, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.4 Asia-Pacific OTC drug And Dietary Supplement Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.5 Asia-Pacific OTC Drug And Dietary Supplement Market: Country Analysis
  • 12.6 China Market
  • 12.7 Summary
    • 12.7.1 Market Overview
    • 12.7.2 Country Information
    • 12.7.3 Market Information
    • 12.7.4 Background Information
    • 12.7.5 Government Initiatives
    • 12.7.6 Regulations
    • 12.7.7 Regulatory Bodies
    • 12.7.8 Major Associations
    • 12.7.9 Taxes Levied
    • 12.7.10 Corporate Tax Structure
    • 12.7.11 Investments
    • 12.7.12 Major Companies
  • 12.8 China OTC drug And Dietary Supplement Market, Segmentation By Category, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.9 China OTC drug And Dietary Supplement Market, Segmentation By Dosage Form, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.10 China OTC drug And Dietary Supplement Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.11 India Market
  • 12.12 India OTC drug And Dietary Supplement Market, Segmentation By Category, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.13 India OTC drug And Dietary Supplement Market, Segmentation By Dosage Form, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.14 India OTC drug And Dietary Supplement Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.15 Japan Market
  • 12.16 Japan OTC drug And Dietary Supplement Market, Segmentation By Category, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.17 Japan OTC drug And Dietary Supplement Market, Segmentation By Dosage Form, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.18 Japan OTC drug And Dietary Supplement Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.19 Australia Market
  • 12.20 Australia OTC drug And Dietary Supplement Market, Segmentation By Category, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.21 Australia OTC drug And Dietary Supplement Market, Segmentation By Dosage Form, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.22 Australia OTC drug And Dietary Supplement Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.23 Indonesia Market
  • 12.24 Indonesia OTC drug And Dietary Supplement Market, Segmentation By Category, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.25 Indonesia OTC drug And Dietary Supplement Market, Segmentation By Dosage Form, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.26 Indonesia OTC drug And Dietary Supplement Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.27 South Korea Market
  • 12.28 South Korea OTC drug And Dietary Supplement Market, Segmentation By Category, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.29 South Korea OTC drug And Dietary Supplement Market, Segmentation By Dosage Form, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.30 South Korea OTC drug And Dietary Supplement Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

13 Western Europe Market

  • 13.1 Summary
    • 13.1.1 Market Overview
    • 13.1.2 Region Information
    • 13.1.3 Market Information
    • 13.1.4 Background Information
    • 13.1.5 Government Initiatives
    • 13.1.6 Regulations
    • 13.1.7 Regulatory Bodies
    • 13.1.8 Major Associations
    • 13.1.9 Taxes Levied
    • 13.1.10 Corporate tax structure
    • 13.1.11 Investments
    • 13.1.12 Major Companies
  • 13.2 Western Europe OTC Drug And Dietary Supplement Market, Segmentation By Category, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.3 Western Europe OTC Drug And Dietary Supplement Market, Segmentation By Dosage Form, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.4 Western Europe OTC Drug And Dietary Supplement Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.5 Western Europe OTC Drug And Dietary Supplement Market: Country Analysis
  • 13.6 UK Market
  • 13.7 UK OTC Drug And Dietary Supplement Market, Segmentation By Category, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.8 UK OTC Drug And Dietary Supplement Market, Segmentation By Dosage Form, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.9 UK OTC Drug And Dietary Supplement Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.10 Germany Market
  • 13.11 Germany OTC Drug And Dietary Supplement Market, Segmentation By Category, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.12 Germany OTC Drug And Dietary Supplement Market, Segmentation By Dosage Form, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.13 Germany OTC Drug And Dietary Supplement Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.14 France Market
  • 13.15 France OTC Drug And Dietary Supplement Market, Segmentation By Category, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.16 France OTC Drug And Dietary Supplement Market, Segmentation By Dosage Form, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.17 France OTC Drug And Dietary Supplement Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.18 Italy Market
  • 13.19 Italy OTC Drug And Dietary Supplement Market, Segmentation By Category, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.20 Italy OTC Drug And Dietary Supplement Market, Segmentation By Dosage Form, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.21 Italy OTC Drug And Dietary Supplement Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.22 Spain Market
  • 13.23 Spain OTC Drug And Dietary Supplement Market, Segmentation By Category, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.24 Spain OTC Drug And Dietary Supplement Market, Segmentation By Dosage Form, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.25 Spain OTC Drug And Dietary Supplement Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

14 Eastern Europe Market

  • 14.1 Summary
    • 14.1.1 Market Overview
    • 14.1.2 Region Information
    • 14.1.3 Market Information
    • 14.1.4 Background Information
    • 14.1.5 Government Initiatives
    • 14.1.6 Regulations
    • 14.1.7 Regulatory Bodies
    • 14.1.8 Major Associations
    • 14.1.9 Taxes Levied
    • 14.1.10 Corporate Tax Structure
    • 14.1.11 Investments
    • 14.1.12 Major Companies
  • 14.2 Eastern Europe OTC drug And Dietary Supplement Market, Segmentation By Category, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 14.3 Eastern Europe OTC drug And Dietary Supplement Market, Segmentation By Dosage Form, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 14.4 Eastern Europe OTC drug And Dietary Supplement Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 14.5 Eastern Europe OTC drug And Dietary Supplement Market: Country Analysis
  • 14.6 Russia Market
  • 14.7 Russia OTC drug And Dietary Supplement Market, Segmentation By Category, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 14.8 Russia OTC drug And Dietary Supplement Market, Segmentation By Dosage Form, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 14.9 Russia OTC drug And Dietary Supplement Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

15 North America Market

  • 15.1 Summary
    • 15.1.1 Market Overview
    • 15.1.2 Region Information
    • 15.1.3 Market Information
    • 15.1.4 Background Information
    • 15.1.5 Government Initiatives
    • 15.1.6 Regulations
    • 15.1.7 Regulatory Bodies
    • 15.1.8 Major Associations
    • 15.1.9 Taxes Levied
    • 15.1.10 Corporate Tax Structure
    • 15.1.11 Investments
    • 15.1.12 Major Companies
  • 15.2 North America OTC Drug And Dietary Supplement Market, Segmentation By Category, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 15.3 North America OTC Drug And Dietary Supplement Market, Segmentation By Dosage Form, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 15.4 North America OTC Drug And Dietary Supplement Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 15.5 North America OTC Drug And Dietary Supplement Market: Country Analysis
  • 15.6 USA Market
  • 15.7 Summary
    • 15.7.1 Market Overview
    • 15.7.2 Country Information
    • 15.7.3 Market Information
    • 15.7.4 Background Information
    • 15.7.5 Government Initiatives
    • 15.7.6 Regulations
    • 15.7.7 Regulatory Bodies
    • 15.7.8 Major Associations
    • 15.7.9 Taxes Levied
    • 15.7.10 Corporate Tax Structure
    • 15.7.11 Investments
    • 15.7.12 Major Companies
  • 15.8 USA OTC Drug And Dietary Supplement Market, Segmentation By Category, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 15.9 USA OTC Drug And Dietary Supplement Market, Segmentation By Dosage Form, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 15.10 USA OTC Drug And Dietary Supplement Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 15.11 Canada Market
  • 15.12 Canada OTC Drug And Dietary Supplement Market, Segmentation By Category, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 15.13 Canada OTC Drug And Dietary Supplement Market, Segmentation By Dosage Form, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 15.14 Canada OTC Drug And Dietary Supplement Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

16 South America Market

  • 16.1 Summary
    • 16.1.1 Market Overview
    • 16.1.2 Region Information
    • 16.1.3 Market Information
    • 16.1.4 Background Information
    • 16.1.5 Government Initiatives
    • 16.1.6 Regulations
    • 16.1.7 Regulatory Bodies
    • 16.1.8 Major Associations
    • 16.1.9 Taxes Levied
    • 16.1.10 Corporate Tax Structure
    • 16.1.11 Investments
    • 16.1.12 Major Companies
  • 16.2 South America OTC Drug And Dietary Supplement Market, Segmentation By Category, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 16.3 South America OTC Drug And Dietary Supplement Market, Segmentation By Dosage Form, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 16.4 South America OTC Drug And Dietary Supplement Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 16.5 South America OTC Drug And Dietary Supplement Market: Country Analysis
  • 16.6 Brazil Market
  • 16.7 Brazil OTC Drug And Dietary Supplement Market, Segmentation By Category, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 16.8 Brazil OTC Drug And Dietary Supplement Market, Segmentation By Dosage Form, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 16.9 Brazil OTC Drug And Dietary Supplement Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

17 Middle East Market

  • 17.1 Summary
    • 17.1.1 Market Overview
    • 17.1.2 Region Information
    • 17.1.3 Market Information
    • 17.1.4 Background Information
    • 17.1.5 Government Initiatives
    • 17.1.6 Regulations
    • 17.1.7 Regulatory Bodies
    • 17.1.8 Major Associations
    • 17.1.9 Taxes Levied
    • 17.1.10 Corporate Tax Structure
    • 17.1.11 Investments
    • 17.1.12 Major Companies
  • 17.2 Middle East OTC drug And Dietary Supplement Market, Segmentation By Category, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 17.3 Middle East OTC drug And Dietary Supplement Market, Segmentation By Dosage Form, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 17.4 Middle East OTC drug And Dietary Supplement Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

18 Africa Market

  • 18.1 Summary
    • 18.1.1 Market Overview
    • 18.1.2 Region Information
    • 18.1.3 Market Information
    • 18.1.4 Background Information
    • 18.1.5 Government Initiatives
    • 18.1.6 Regulations
    • 18.1.7 Regulatory Bodies
    • 18.1.8 Major Associations
    • 18.1.9 Taxes Levied
    • 18.1.10 Corporate Tax Structure
    • 18.1.11 Investments
    • 18.1.12 Major Companies
  • 18.2 Africa OTC drug And Dietary Supplement Market, Segmentation By Category, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 18.3 Africa OTC drug And Dietary Supplement Market, Segmentation By Dosage Form, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 18.4 Africa OTC drug And Dietary Supplement Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

19 Competitive Landscape And Company Profiles

  • 19.1 Company Profiles
  • 19.2 Nestle S.A.
    • 19.2.1 Company Overview
    • 19.2.2 Products And Services
    • 19.2.3 Business Strategy
    • 19.2.4 Financial Overview
  • 19.3 The Procter & Gamble Company
    • 19.3.1 Company Overview
    • 19.3.2 Products And Services
    • 19.3.3 Financial Overview
  • 19.4 Haleon plc
    • 19.4.1 Company Overview
    • 19.4.2 Products And Services
    • 19.4.3 Business Strategy
    • 19.4.4 Financial Overview
  • 19.5 Abbott Laboratories
    • 19.5.1 Company Overview
    • 19.5.2 Products And Services
    • 19.5.3 Business Strategy
    • 19.5.4 Financial Overview
  • 19.6 Sanofi S.A
    • 19.6.1 Company Overview
    • 19.6.2 Products And Services
    • 19.6.3 Business Strategy
    • 19.6.4 Financial Overview

20 Other Major And Innovative Companies

  • 20.1 Reckitt Benckiser Group plc
    • 20.1.1 Company Overview
    • 20.1.2 Products And Services
  • 20.2 Bayer AG
    • 20.2.1 Company Overview
    • 20.2.2 Products And Services
  • 20.3 Church & Dwight Co. Inc
    • 20.3.1 Company Overview
    • 20.3.2 Products And Services
  • 20.4 Nature's Bounty Co
    • 20.4.1 Company Overview
    • 20.4.2 Products And Services
  • 20.5 Perrigo Company plc
    • 20.5.1 Company Overview
    • 20.5.2 Products And Services
  • 20.6 GNC Holdings Inc.
    • 20.6.1 Company Overview
    • 20.6.2 Products And Services
  • 20.7 Sun Pharmaceutical Industries Ltd
    • 20.7.1 Company Overview
    • 20.7.2 Products And Services
  • 20.8 Novartis AG
    • 20.8.1 Company Overview
    • 20.8.2 Products And Services
  • 20.9 Pfizer Inc
    • 20.9.1 Company Overview
    • 20.9.2 Products And Services
  • 20.10 Merck & Co. Inc
    • 20.10.1 Company Overview
    • 20.10.2 Products And Services
  • 20.11 Pharmavite LLC
    • 20.11.1 Company Overview
    • 20.11.2 Products And Services
  • 20.12 Hain Celestial Group Inc
    • 20.12.1 Company Overview
    • 20.12.2 Products And Services
  • 20.13 Blackmores Limited
    • 20.13.1 Company Overview
    • 20.13.2 Products And Services
  • 20.14 Cipla Inc
    • 20.14.1 Company Overview
    • 20.14.2 Products And Services
  • 20.15 Amway
    • 20.15.1 Company Overview
    • 20.15.2 Products And Services

21 Competitive Benchmarking

22 Competitive Dashboard

23 Key Mergers And Acquisitions

  • 23.1 Dr. Reddy's Laboratories Acquired MenoLabs
  • 23.2 Dexcel Pharma Acquired Teva Pharmaceutical Industries Ltd
  • 23.3 Cipla Limited Acquired Actor Pharma
  • 23.4 SGS S.A. Acquired Nutrasource Pharmaceutical and Nutraceutical Services Inc.
  • 23.5 The Kirin Holdings Company Limited Acquired Blackmores Limited
  • 23.6 Balchem Corporation Acquired Bergstrom Nutrition
  • 23.7 Glenmark Pharmaceuticals Ltd Acquired Wockhardt Ltd
  • 23.8 Acino Acquired Aspen Pharmacare Holdings Limited
  • 23.9 Douglas Acquired Disapo
  • 23.10 Merieux NutriSciences Acquired Dyad Labs
  • 23.11 Laboratorios Rubio Acquired Fisiopharma S.r.l.
  • 23.12 Fidia Farmaceutici Acquired Sanofi

24 Opportunities And Strategies

  • 24.1 Global OTC Drug And Dietary Supplement Market In 2028 - Countries Offering Most New Opportunities
  • 24.2 Global OTC Drug And Dietary Supplement Market In 2028 - Segments Offering Most New Opportunities
  • 24.3 Global OTC Drug And Dietary Supplement Market In 2028 - Growth Strategies
    • 24.3.1 Market Trend Based Strategies
    • 24.3.2 Competitor Strategies

25 OTC Drug And Dietary Supplement Market, Conclusions And Recommendations

  • 25.1 Conclusions
  • 25.2 Recommendations
    • 25.2.1 Product
    • 25.2.2 Place
    • 25.2.3 Price
    • 25.2.4 Promotion
    • 25.2.5 People

26 Appendix

  • 26.1 Geographies Covered
  • 26.2 Market Data Sources
  • 26.3 Research Methodology
  • 26.4 Currencies
  • 26.5 The Business Research Company
  • 26.6 Copyright and Disclaimer